Welcome to LookChem.com Sign In|Join Free

CAS

  • or

109963-61-3

Methyl 4-(4-formylphenyl)benzoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

109963-61-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 109963-61-3 Structure

  • Basic information

    1. Product Name: Methyl 4-(4-formylphenyl)benzoate
    2. Synonyms: 4-(4-Methoxycarbonylphenyl)benzoic acid
    3. CAS NO:109963-61-3
    4. Molecular Formula: C15H12O4
    5. Molecular Weight: 256.25
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 109963-61-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 439.3°Cat760mmHg
    3. Flash Point: 167.1°C
    4. Appearance: /
    5. Density: 1.249g/cm3
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.593
    8. Storage Temp.: 2-8°C
    9. Solubility: N/A
    10. CAS DataBase Reference: Methyl 4-(4-formylphenyl)benzoate(CAS DataBase Reference)
    11. NIST Chemistry Reference: Methyl 4-(4-formylphenyl)benzoate(109963-61-3)
    12. EPA Substance Registry System: Methyl 4-(4-formylphenyl)benzoate(109963-61-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 109963-61-3(Hazardous Substances Data)

109963-61-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 109963-61-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,9,9,6 and 3 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 109963-61:
(8*1)+(7*0)+(6*9)+(5*9)+(4*6)+(3*3)+(2*6)+(1*1)=153
153 % 10 = 3
So 109963-61-3 is a valid CAS Registry Number.
InChI:InChI=1/C15H12O4/c1-19-15(18)13-8-4-11(5-9-13)10-2-6-12(7-3-10)14(16)17/h2-9H,1H3,(H,16,17)

109963-61-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(4-methoxycarbonylphenyl)benzoic acid

1.2 Other means of identification

Product number -
Other names 4'-(Methoxycarbonyl)[1,1'-biphenyl]-4-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:109963-61-3 SDS

109963-61-3Relevant articles and documents

N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS

-

Page/Page column 49-50, (2009/05/29)

The present invention relates to a novel class of N-hydroxy-naphthalene dicarboxamide and N-hydroxy-biphenyl-dicarboxamide derivatives. The N-hydroxy-naphthalene dicarboxamide and N-hydroxy-biphenyl-dicarboxamide compounds can be used to treat cancer. The N-hydroxy-naphthalene dicarboxamide and N-hydroxy-biphenyl-dicarboxamide compounds can also inhibit histone deacetylase and are suitable for use in selectively inducing terminal differentiation, and arresting cell growth and/or apoptosis of neoplastic cells, thereby inhibiting proliferation of such cells. Thus, the compounds of the present invention are useful in treating a patient having a tumor characterized by proliferation of neoplastic cells. The compounds of the invention may also be useful in the prevention and treatment of TRX-mediated diseases, such as autoimmune, allergic and inflammatory diseases, and in the prevention and/or treatment of diseases of the central nervous system (CNS), such as neurodegenerative diseases. The present invention further provides pharmaceutical compositions comprising the N-hydroxy-naphthalene dicarboxamide and N-hydroxy-biphenyl-dicarboxamide derivatives and safe dosing regimens of these pharmaceutical compositions, which are easy to follow, and which result in a therapeutically effective amount of the N-hydroxy-naphthalene dicarboxamide and N-hydroxy-biphenyl-dicarboxamide derivatives in vivo.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 109963-61-3